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Abstract
Objectives The overuse of antimalarial drugs is widespread. Effective
methods to improve prescribing practice remain unclear. We evaluated
the impact of 10 interventions that introduced rapid diagnostic tests
for malaria (mRDTs) on the use of tests and adherence to results in
different contexts.
Design A comparative case study approach, analysing variation in
outcomes across different settings.
Setting Studies from the ACT Consortium evaluating mRDTs with a
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range of supporting interventions in 6 malaria endemic countries.
Providers were governmental or non-governmental healthcare
workers, private retail sector workers or community volunteers. Each
study arm in a distinct setting was considered a case.
Participants 28 cases from 10 studies were included, representing 148 
461 patients seeking care for suspected malaria.
Interventions The interventions included different mRDT training
packages, supervision, supplies and community sensitisation.
Outcome measures Analysis explored variation in: (1) uptake of mRDTs
(% febrile patients tested); (2) provider adherence to positive mRDTs (%
Plasmodium falciparum positive prescribed/given Artemisinin
Combination Treatment); (3) provider adherence to negative mRDTs (%
P. falciparum negative not prescribed/given antimalarial).
Results Outcomes varied widely across cases: 12–100% mRDT uptake;
44–98% adherence to positive mRDTs; 27–100% adherence to
negative mRDTs. Providers appeared more motivated to perform well
when mRDTs and intervention characteristics fitted with their own
priorities. Goodness of fit of mRDTs with existing consultation and
diagnostic practices appeared crucial to maximising the impact of
mRDTs on care, as did prior familiarity with malaria testing; adequate
human resources and supplies; possible alternative treatments for
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mRDT-negative patients; a more directive intervention approach and
local preferences for ACTs.
Conclusions Basic training and resources are essential but insufficient
to maximise the potential of mRDTs in many contexts. Programme
design should respond to assessments of provider priorities,
expectations and capacities. As mRDTs become established, the
intensity of supporting interventions required seems likely to reduce.
http://dx.doi.org/10.1136/bmjopen-2016-012973
Statistics from Altmetric.com
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Strengths and limitations of this study
This analysis addresses the gap in knowledge around how
to change prescribing practices, a key question in the era of
resistance to antimicrobial medicines.
The analysis exploits indepth data from 10 intervention
studies connected through the ACT Consortium in order to
explore the reasons for variation in trial outcomes.
A comparative case study approach was used, allowing
trends and patterns to be explored across contexts in a way
not possible within single studies.
By analysing studies conducted within a consortium,
access to unpublished documents, raw data and qualitative
insights from the study teams allowed a deeper
understanding of the studies and their contexts than is
often found in systematic reviews of published reports.
The extent of variation across the study arms in terms of
context, provider type, intervention content and study
design allowed for exploration of a range of factors
affecting outcomes, but also created challenges for
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comparability, necessitating a case study approach.
Background
The substantial overdiagnosis of malaria as a cause of acute febrile
illness has been the focus of global attention in recent years,1–3 given
concerns about the clinical effects of misdiagnoses, the cost of first-
line artemisinin-based combination therapies (ACTs) and emerging
malaria drug resistance.4 5 A policy of universal parasitological testing
for malaria was introduced by the WHO in 2010,6 aiming to reduce
overprescription of ACTs.2 Malaria rapid diagnostic tests (mRDTs) have
been developed for use in low-resource settings, making parasite-
based testing possible where microscopy may not be available or
feasible.4
RDTs have been introduced with providers in a range of sectors.7
However, evidence from evaluations of mRDT introductions show
mixed effects; mRDTs do not lead to improved targeting of ACTs if
providers do not consistently use the tests or if they ignore test
results.8–12 To maximise their potential for improving prescribing
practices, evidence is required of the relative success and challenges
of different types of mRDT intervention in different contexts.
,
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This paper presents an analysis of the findings from 10 mRDT
intervention studies conducted in Africa and Afghanistan, for which
indepth information was available about interventions, outcomes and
contexts. The studies, all from the ACT Consortium, represent a large
proportion of the intervention studies on mRDTs recently conducted in
areas of ongoing malaria transmission. This analysis aimed to identify
how mRDTs can be used to improve prescribing in different contexts by
exploring factors influencing providers' use of and adherence to test
results and comparing results of interventions in different settings.
Methods
The ACT Consortium is an international research collaboration
involving more than 20 institutions working on a systematic series of
25 studies in 10 countries in Africa and Asia, addressing practical
questions in the delivery of malaria treatment.13 Intervention studies
involving mRDTs were conducted in 10 sites in 6 countries. The
analysis in this paper focuses on these studies because of the ability it
gives to use raw outcome data (allowing comparable outcomes to be
calculated), raw data from linked qualitative research, unpublished
documentation about intervention content, implementation and
contextual information as well as insights from the study teams. This
allowed a more detailed and comparable analysis than could be
achieved through reliance on publications or quantitative data alone.
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This analysis used a comparative case study approach, where each
study arm conducted in a distinct setting was considered a case and
outcomes were interpreted in terms of the study design, intervention
content, implementation and contextual factors.14 This approach suits
investigation of ‘how’ and ‘why’ interventions have an effect and can
highlight comparative general trends and distinct patterns that are not
visible in single cases.15 17 The analysis explored three outcomes:
Provider uptake of mRDTs.
The proportion of patients presenting with fever, or history of
fever in past 48 hours (unless specified otherwise), who were
tested for malaria with an mRDT, as reported by the provider or
patient.
Provider adherence to positive mRDT results.
The proportion of patients with a positive mRDT result (for
Plasmodium falciparum malaria), who were prescribed or received
an ACT, the first-line drug for non-severe malaria in all cases, as
reported by provider or patient.
Provider adherence to negative mRDT results.
The proportion of patients with a negative mRDT result who were
not prescribed, or did not receive, any antimalarial as reported by
,
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provider or patient (the effect of negative mRDT results on the
use of other treatments, including antibiotics, in ACT Consortium
studies has been presented in a separate paper).16
The analysis evaluated the impact of different interventions to
introduce mRDTs in different contexts. Twenty-eight cases (ie, distinct
settings or intervention arms) from the 10 studies were included, with a
total of 148 461 patients (see table 1). Twenty cases from 7 studies
analysed mRDT uptake, 24 cases from 9 studies evaluated provider
adherence to positive mRDT results and all 28 cases analysed provider
adherence to negative mRDT results.
Table 1
Cases included in analysis
The studies took place between 2007 and 2012. Studies were either
individual (n=2) or cluster-randomised controlled trials (n=6);
observational (n=2) or preintervention/postintervention studies (n=1)
(Tanz2 used different designs in their pilot and main study, so n=11).
Providers targeted were governmental or non-governmental
healthcare workers, private retail sector workers or community health
volunteers. Six studies took place in East Africa, three in West
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Africa  and one in south-central Asia . One focused only
on children under 5 years ; the rest included children and adults. See
online supplementary file 1 for more detailed information about each
study.
supplementary ﬁle
[bmjopen-2016-012973supp1.pdf]
All the interventions included basic training on malaria testing with
RDTs for healthcare providers, however the content, duration and
approach varied. Some interventions included additional activities and
materials such as extra training, supervision and feedback, patient
information leaflets or school-based activities (see table 2 and online
supplementary file 1).
Table 2
Intervention content
Three studies compared different training packages . Six
studies compared intervention effects in different epidemiological
contexts . Seven studies evaluated an
intervention against a control arm where mRDTs were not made
Cam1,Nig1,Ghan1 Afgh1
Uga2
Nig1,Cam1,Tanz2
Uga2,Tanz1,Nig1,Cam1,Afgh1,Ghan1
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available .
Comparability of ﬁndings
Although the studies were co-designed and largely similar, because of
differences in primary study questions and differences in
epidemiology, data collection methods and evaluation timing, mean
pooled analyses would be inappropriate. For example, mRDT uptake
was reported through provider-completed registers in some projects
and patient exit interviews in others. Some studies reported adherence
in terms of the percentage of patients prescribed ACTs or antimalarials,
while others reported the percentage of patients who received them.
Stockouts may have affected receipt of medication; whether
prescriptions were affected is unknown, as alternative medication may
or may not have been offered when there was a known stockout. The
analysis presented therefore focuses on understanding the reasons for
variation in the results, rather than seeking pooled point estimates.
Quantitative outcome data were extracted from each study's raw data
set and reanalysed to maximise comparability across studies, using the
most comparable denominators and numerators possible. Study,
intervention and context characteristics were extracted from
published and unpublished documents. Where available, thematic
content analysis was undertaken on qualitative data from providers
involved in the studies (ie, focus group discussions  or
Uga1,Uga2,Uga3,Nig1,Cam1,Afgh1, Ghan1
Uga2,Uga3
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interviews  with health workers, drug shop
vendors or volunteers). In Tanz3, interviews from a later, related study
were analysed, which included six study providers and six similar
providers who had not been involved in the study but had comparable
mRDT experiences.
The analysis drew on the approaches informing intervention
component analysis (ICA)52 and qualitative comparative analysis
(QCA),53 which seek to identify critical features of interventions. As
with ICA, we sought to identify how interventions differed from one
another and then, as with QCA, identify which factors appeared to be
important. Our initial stage involved gathering as much information
about the interventions as possible, going broader than the ICA
approach by also capturing information about their delivery and
context. However, our analysis differed from ICA and QCA, which
attempt to characterise and apply scores to interventions and their
characteristics and cross-tabulate these with outcomes. We found our
data were not amenable to scoring in a quantitative sense, due to wide
variation in the extent and types of information available. Therefore,
our analysis was qualitative, using a meaning-based approach. Tables
were created for each outcome of interest, with explanatory factors
relating to the intervention, context and study design (see online
supplementary file 2 for an example). These were shared with study
Afgh1,Ghan1,Tanz1/a,Tanz1/b,Tanz2,Uga1
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teams and the ACT Consortium core scientific team, with ongoing
discussions about the findings and other potential explanatory factors.
supplementary ﬁle
[bmjopen-2016-012973supp2.pdf]
Results
There was wide variation across cases in all three outcomes: 12–100%
mRDT uptake (figure 1A); 44–98% adherence to positive mRDTs (figure
1B); 27–100% adherence to negative mRDTs (figure 1C). All outcomes
were universally high in some cases  and universally low in
others , but in many cases, the three outcomes did not
correspond—for example, testing was infrequent but adherence to
results high  or adherence to positives high, but
negatives low , or vice versa .
Uga1,Uga2/b,Uga3
Nig1/a1,Nig1/a3
Tanz1/a,Tanz1/b,Tanz2/3
Ghan1/a,Ghan1/b,Cam1/a1,Cam1/b1 Uga2/a,Nig1/b3
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Figure 1
(A) Uptake of malaria rapid diagnostic tests (mRDTs) (% patients with fever or history
of fever who were tested for malaria with an mRDT). (B) Adherence to positive mRDT
results (% of patients with a positive mRDT who did NOT receive ACTs). (C) Adherence
to negative mRDTs (% of patients with a negative mRDT results who received
antimalarials).
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There were no single factors which alone accounted for any of the
outcomes; successful mRDT uptake and adherence appeared to result
from a combination of context and intervention characteristics. The
analysis identified several factors which, taken together, may account
for the heterogeneity observed. The appeal of the intervention to
providers was crucial for all three outcomes, but each was additionally
shaped by other factors.
Factors affecting mRDT uptake
There was wide variation between cases in the use of mRDTs for febrile
patients (see figure 1A). Providers' motivation to perform well in the
intervention was associated with uptake, as were familiarity with
testing, adequate human resources and supplies, and the cost of
mRDTs.
Motivation to perform well in the intervention
The range of sectors and contexts in which providers worked meant
that their own priorities varied between cases. For example,
government health workers' priorities may have included some or all of
the following: treating ill patients, managing their workload in the light
of staff shortages, managing (or ‘rationing’) their medicine supplies in
the face of future shortages, maintaining their position of authority as a
clinician. In contrast, while private providers may also have prioritised
pdfcrowd.comopen in browser PRO version Are you a developer? Try out the HTML to PDF API
treating ill patients, some viewed their role as more of a business than a
healthcare service. As such, their priorities may have been more
business-oriented, such as making a profit and ensuring sufficient
customers.
Data on provider priorities were not available for all cases; for some,
qualitative data were available but for others, anecdotal evidence and
study team perceptions were used. Nevertheless, where the intended
use of mRDTs and associated intervention activities aligned well with
providers' own priorities, they appeared more motivated to participate
and ‘perform’ well in the intervention, and we observed higher uptake
and adherence. There were a number of explanations for, and/or
factors associated with, higher motivation but political and financial
support were often critical. For example, in Tanz2, carefully developed
messages addressing existing provider principles and practices, as well
as Ministry of Health branding of the intervention (an institution known
to influence the government health workers in this setting), appeared
to motivate providers. In Uga3, the drug shop vendors were previously
not permitted to offer testing and this new service, along with the
associated training, supervision and visible involvement of the Ministry
of Health, gave them a legitimacy they had previously lacked.48 These
vendors also reported increased customer numbers and associated
profits, enhanced by the study's free provision of mRDTs and ACTs for
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them to sell at a subsidised rate. In Tanz3, government providers were
paid a supplement to participate in the study. Additional unintentional
aspects of studies, such as regular visits or perceived support from
evaluators, may have also helped to improve outcomes .38
In contrast, where mRDT interventions were not aligned with provider
priorities, we saw lower uptake and adherence. For example, in Nig1 in
the private sector, providers saw themselves more as vendors than
healthcare practitioners. Here, there were anecdotal reports that they
were particularly concerned about losing money from sales if mRDT
results were negative and wondered whether the public would
consider them legitimate to test. This was the case in spite of the free
provision of mRDTs to providers by the study team. When providers
viewed the intervention as extra unpaid work (eg, conducting tests or
recording test results), this affected their motivation. In Uga3, some
drug shops declined to participate in the trial for this reason and in
Uga1, some health facilities hesitated to continue participating when
they felt the work was too much without remuneration. Here, a
misalignment between the providers' priorities and the intentions of
the intervention led to a lack of motivation for providers to perform in
line with guidelines.
Familiarity with testing
Uga3,Tanz2
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In most cases, there was little prior experience of malaria testing, either
using mRDT or microscopy. Although patients were generally keen to
be tested for malaria, it was not typically part of providers' routine
habits to test. In cases where testing had become part of the
established process of care, mRDT uptake tended to be higher. For
example, in Tanz1/c, mRDTs had already been scaled up in other
districts in recent years, and at baseline there was substantial
microscopy testing, unlike the other two cases in this study where
uptake was lower . Wide-scale public awareness of testing
may have facilitated uptake, for example, in Cameroon, where mass
communication campaigns coincided with the study , which saw an
increase in malaria testing in all study arms from baseline.23 Some
interventions incorporated local community sensitisation activities to
increase familiarity , although this appeared
insufficient on its own to ensure high uptake.
Adequate human resources and supplies
Where staff workload was high, or patient numbers exceeded capacity,
particularly in small facilities with only one staff member, mRDTs were
not always used .
There were adequate stocks of mRDTs in facilities in most studies, in
several cases due to study provision of additional supplies to avert
Tanz1/a,Tanz1/b
Cam1
Uga2,Uga3,Tanz2/4,Nig1/3
Uga1,Tanz2/1
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stockouts. However, stockouts did occur in some studies ,
which was associated with lower uptake to some extent. Nevertheless,
even when mRDTs were available, they were not always used,
suggesting other factors were also influential.
Cost of mRDTs to patients
In most studies, mRDTs were provided free to patients. In those cases
where providers were permitted to charge patients for mRDTs, higher
prices may have affected their uptake. For example in Nig1, where
mRDT uptake was among the lowest observed, patients were charged
more than the recommended price on average, particularly in the
private sector.
Factors affecting adherence to positive mRDT results
ACTs were not consistently prescribed to patients with positive mRDT
results (see figure 1B). Given the expectation for antimalarial overuse
based on previous data, this finding was not anticipated and reasons for
low adherence to positive results were therefore not explicitly explored
during the studies. However, some explanatory factors driving this
outcome did emerge, in addition to the motivation to perform well in
the intervention (discussed above). These were the stability of ACT
supplies and local preferences for different types of antimalarial.
Cam1,Tanz1,Tanz2
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Stability of ACT supplies
Stockouts of ACTs were associated with variation in adherence to
positive mRDT results; however, this could not explain all the variation.
In some cases, ACT use was relatively low despite no or few stockouts,
whereas in others, use was high despite stockouts occurring. It may be
that provider confidence in the stability of ACT supplies also
influenced the use and rationing of ACTs, even when ACTs were
available. For example, in Tanz2, lower rates of adherence to positive
mRDTs were observed in the case where stockouts were most
frequent , even after periods of stockouts were excluded from the
analysis.
Pre-existing antimalarial preferences
Information on pre-existing antimalarial preferences was gathered
from baseline and preintervention surveys,32 49 interview
transcripts  and unpublished reports,54 although no data were
available for five studies . The data suggest an
association between the use of ACTs for positive mRDTs and baseline
preferences for, or use of, ACTs rather than other antimalarials. For
example, in Nig1, where ACT use was generally low, prior to the
intervention, other antimalarials were asked for by patients, prescribed
and purchased more commonly than ACTs.34 In contrast, in Tanz1,
where adherence to RDT positive results was higher, according to
Tanz2/4
,
Tanz1
Afgh1,Ghan1,Tanz3,Uga1,Uga2
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stakeholder interviews, ACTs were patients' preferred antimalarial. This
may have been due to greater exposure to community sensitisation
around ACTs55 or cultural norms around provider authority such that
patients felt more inclined to change their preferences in the light of
providers' guidance than was the case in Nigeria. An alternative
explanation relates to the different roles of the public sector in these
countries and therefore, the different influence that the choice of
official first-line medicines has on preferences. For example, in
Tanzania, public facilities are much more widely used that they are in
Nigeria, so people will have become used to the idea of ACTs. In
Nigeria, the public sector is a more limited provider, so making a drug
officially first line may have much less effect on preferences.
Factors affecting adherence to negative mRDT results
There was also wide variation in the proportion of patients prescribed
or given antimalarials in spite of negative mRDT results (see figure 1C).
In addition to being motivated to perform well in the intervention
(discussed above), the analysis suggests adherence to negative mRDTs
was also driven in part by the extent to which mRDTs fitted—or were
helped by intervention activities to fit—into the existing landscape of
care (existing diagnostic and consultation practices). This included
providers' perceptions of the role of mRDTs in the diagnostic process
and possibilities for alternative diagnoses and treatment. In addition,
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the analysis suggests that adherence was affected by the extent to
which the interventions attempted to control clinical practice.
Malaria tests were usually the only diagnostics available in study
facilities. In most cases, test-based malaria diagnosis required a
substantial shift from reliance on clinical judgement. In a minority of
cases, this shift had already begun before the evaluation started, for
example, in Tanzania and Zanzibar where mRDT introductions had
begun nationally , or where malaria testing using microscopy
was established . Here, mRDTs appeared to fit into the
landscape of care more easily and adherence to negative mRDT results
was higher. Where testing was new and did not fit into the landscape of
care so well, even if mRDT use was attractive, adhering to negative
results appeared more difficult .
Two factors appeared to facilitate integration of mRDTs into the
landscape of care: providers' perceptions of the role of mRDTs in the
diagnostic process and whether alternative management of illnesses,
not involving antimalarials, was possible for those with negative mRDT
diagnoses.
Perceived role of mRDTs in diagnostic process
Two main factors influenced providers' perceptions of the role of
mRDTs within the process of malaria diagnosis: how well mRDTs fitted
Tanz1,Tanz3
Afgh1/a,Afgh1/b,Tanz1/c
Afgh1/c,Cam1,Ghan1,Nig1
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with the dynamic of consultations and whether the mRDT results
matched their expectations.
In some cases, providers saw mRDTs as central to the diagnostic
process. For example, community health volunteers in Uga2, whose
adherence was very high, described the mRDTs as working as ‘a judge’,
and drug shop vendors in Uga3 saw taking blood as crucial to their
enhanced role. Conversely, some providers felt clinical judgement
should play a more important role in making a diagnosis than mRDTs.
Qualitative data suggested that where mRDTs challenged clinicians'
expertise and disrupted traditional consultation practices, this led to
lower adherence to negative results . By questioning the
test's accuracy, providers were able to reassert their authority and
manage the consultation as usual.18 36
Some interventions aimed to help mRDTs ‘fit’ with the dynamics of
consultations. For example, training included role-play activities or
reflections about how mRDTs would work in practice ,
experimentation  and reflection facilitated by multiple
training and feedback sessions with peers ;
and training on communicating with patients
. Providers reported positive impressions of the
training's impact on their interactions with patients including the
importance of talking to patients and explaining the need for mRDTs or
Afgh1,Ghan1,Tanz2/1
,
Cam1/2,Uga1,Uga3
Tanz2/3. Tanz2/4
Cam1/2,Tanz2/3,Tanz2/4,Uga1,Uga2,Uga3
Cam1/2,Nig1/2,
Tanz2/3,Tanz2/4,Uga1,Uga 2,Uga3
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the meaning of their results .
In some cases, mRDT results did not match expectations; typically,
fewer mRDTs were positive than had been expected, particularly when
the tests were first introduced . When this happened,
providers placed less emphasis on mRDTs in the diagnostic process,
preferring to rely more heavily on clinical judgement. For example, in
Cam1/a1, mRDT positivity rates were just 9%, despite the local
perception that malaria prevalence was high in that area. Several
interviewees from different cases explained that it was hard to trust
mRDTs when so many results were negative ,
or that they only trusted them once they had seen some positive
mRDT results . Providers described a fear of missing malaria
diagnoses, particularly when the frequency of positive results was
lower than expected, and this was associated with lower
adherence . In contrast, providers in Tanz3, where
adherence to negative mRDTs was high, appeared less concerned
about malaria, recognising that prevalence had declined. Some
interventions explicitly aimed to raise awareness of current malaria
epidemiology during training  in order to (re)set
expectations of mRDT positivity rates; this was also associated with
higher adherence to negative results.
In several cases, providers reported that their trust in mRDTs grew over
Ghan1,Tanz2/1,Tanz2/3,Tanz1/a,Uga2
Uga3,Tanz2/4,Ghan,1/2
Ghan1/b,Nig1,Tanz1/b,Tanz2/4,Uga3
Uga2,Tanz2/4
Ghan1/1,Ghan1/2,Tanz1/b
Tanz2/3,Tanz2/4,Uga1
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time . Some described deliberate
‘experimentation’ to build trust in results, either by testing with
microscopy as well as mRDTs  or by seeing whether mRDT-negative
patients recovered without antimalarials . Indeed in one study,
this was explicitly encouraged . Conversely, some providers'
accounts showed mistrust of mRDTs was reinforced by experiences of
seeing patients, or indeed themselves, recover when taking
antimalarials in spite of a negative mRDT result . Patient
follow-up was considered another useful means of building trust
. Two interventions aimed to increase the perceived role of
mRDTs by providing information about mRDTs' sensitivity and
specificity .36
Alternative treatments for non-malarial fever patients
Interventions offered different options for dealing with mRDT-negative
patients (as mentioned above, data on the use of alternative
treatments are presented in a separate paper). It appeared that
expectations and options for alternative management of negative
cases—in terms of providers' role, knowledge of case management
and availability of other medicines—were important in antimalarial
prescribing to mRDT-negative patients. In the public facility
interventions where detailed guidance was given to aid alternative
diagnoses , adherence was higher than in public facilities
Tanz3, Tanz2/2, Tanz2/3, Uga3
Afgh1
Ghan1,Uga2
Tanz2/3, Tanz2/4
Uga2/b,Ghan1/a
Uga2,
Ghan1/b
Tanz1,Tanz2/3,Tanz2/4
Uga1,Tanz2,Tanz3
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where no substantial guidance was provided  or where it was
recommended that providers only offer antipyretics to mRDT-negative
patients . At the community level, where volunteer providers
were not expected (or permitted) to provide medicines beyond
antimalarials , adherence to negative results was high. In private
shops in Uganda, where no training on non-malarial febrile illness
management was provided, adherence to mRDT-negative results was
still high in terms of ACT prescription, although here mRDT-negative
patients ended up being sold other medicines .
Directive intervention approach
Some interventions were more directive about provider practices,
particularly regarding the use of unambiguous guidance and
supervision or surveillance.
Adherence was typically higher if interventions instructed that no
antimalarial should be given to those with negative mRDT
results . In contrast, adherence was lower when an
intervention allowed exceptions for when antimalarials could be given
in spite of a negative result, for example, if a febrile patient was under 5 
years and had travelled a long distance to seek care .
The highest adherence was observed among providers who had been
closely supervised—either for an intense period after training
Ghan1,Afgh1
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Uga3
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or throughout the evaluation period . Providers receiving feedback
by text message experienced these as a form of surveillance, and
reported responding by feeling they should follow guidelines even if
their clinical judgement was at odds with this .
Discussion
This analysis addresses the persisting gap in knowledge around how to
change prescribing practices. This is a key question in this time of
international concern over resistance to antimicrobial medicines, with
the imperative to optimise medicine use agreed on by United Nations
signatories.56 57 By analysing indepth data from 10 co-designed
intervention studies from the ACT Consortium, we identify factors
affecting the uptake of mRDTs and adherence to test results in
different contexts. The varied findings suggest that to improve
prescribing through mRDTs, interventions must go beyond basic
training in mRDT use and must be tailored to the needs of providers in
particular contexts. Uptake and adherence were highest where
providers were motivated by the intervention and the tests fitted with
the landscape of care. Intervention characteristics that aligned mRDTs
with provider priorities included interactive training that addressed
how to manage test-negative patients in practice, including clinical
and interpersonal aspects of care. Where malaria endemicity is
Tanz3
Tanz2/3,Tanz2/4
,
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overestimated locally, experimentation and feedback on frequent test-
negative cases was important. A directive approach supported by
feedback or supervisory instruction can yield high adherence to
guidelines but may affect patient-centred care. The results suggest
that as mRDTs become established, the intensity of supporting
interventions required is likely to reduce.
A strength of this analysis was its use of rich data sources which
enabled a more indepth and comprehensive analysis. Although
additional insights may have emerged from inclusion of a wider set of
studies, synthesising findings from published healthcare interventions
is often challenging, with diverse and poorly described interventions,
contexts and methods.58 59 Nevertheless, our analysis was limited by
the fact that not all included studies were able to provide information
on all characteristics of interest, while for other characteristics (eg, year
and duration), there was too much variation to identify any patterns.
While study samples were generally sizeable, in some cases where
testing rates and/or malaria prevalence were low, the denominator for
adherence outcomes was small. With one exception, where a
government mRDT policy was evaluated , all of the evaluated
interventions in this analysis were instigated by the study teams. As
such, there may be aspects of the interventions, such as RDT supply
sources and costs to providers, which may not apply at scale.
,
Tanz1
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Previous studies have identified capacity issues as important in mRDT
implementation, such as staffing levels or overworked staff,9 12 60–64
mRDT or ACT supplies,9 12 61–65 and providers' confidence in mRDT
results.12 61–66 Our synthesis shows that beyond these issues, the
introduction of the tests had to make sense in context. Some
interventions in our analysis additionally included a more directive
approach. While these interventions did achieve the highest rates of
adherence to negative results, the consequences of restricting the
autonomy of clinicians in favour of standardised guidelines need to be
weighed up against the need for clinicians to consider individual
patients on a case-by-case basis.67 Our finding, that settings where
testing was more familiar used mRDTs more appropriately, echoes
observations from country-level roll-out of mRDTs,68 69 and suggests
that the interventions required will change over time. Our finding, that
basic training alone is insufficient to ensure use of the tests as
intended, aligns with findings from studies of interventions aiming to
change clinical practice in general.4 70
Prior to introducing mRDTs, initial assessments should be carried out to
understand providers' priorities and capacities, as well as how easily
tests might integrate into landscapes of care. Although our analysis
suggests that a process of tailoring is required to formulate the
intervention to best fit each context, certain broad intervention
, ,
, ,
,
,
,
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Box 1 Examples of recommended intervention
features
Planning
Recognise and address providers’ priorities
Staffing
Ensure sufficient staff numbers for increased workload
Training
Offer longer, more detailed training, incorporating
interactive activities
Include training on communicating with patients
Address process of change to test-based care:
plan a series of interactive training and/or
supervision sessions
features are likely to be applicable across settings (see box 1). As these
recommendations arise directly from the data available in our studies,
they are not exhaustive.
pdfcrowd.comopen in browser PRO version Are you a developer? Try out the HTML to PDF API
incorporate role-play activities which address
local challenges
use reflective activities
Build trust in mRDTs by including:
discussion of data on changes in malaria
prevalence in the area
discussion of sensitivity and specificity of mRDTs
encouragement to cross-check these data with
experience of tests in practice
Guidance
Provide detailed guidance and resources for acceptable
case management for mRDT-negative patients
Consider how directive mRDT guidance should be,
balancing clarity with the need for clinician judgement to
make exceptions (eg, if patients have travelled far, with
limited means of transportation to return if their condition
worsens)
Medical supplies
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Ensure providers can be confident in supplies of mRDTs
and ACTs
Keep costs to patients low
Community/patient sensitisation
Conduct patient-oriented sensitisation activities
where familiarity with testing is low, where
frequent false-positive microscopy has
overestimated prevalence, or if ACTs are not the
most common antimalarial used or demanded by
patients
These findings can inform broader antimicrobial stewardship efforts.
Malaria is the first disease for which interventions have been
systematically evaluated in order to understand how to change routine
prescribing through rapid diagnostics. The lessons learnt in attempting
to shift from presumptive to test-directed treatment are relevant for
interventions beyond malaria. The intervention and contextual
characteristics identified here highlight that apparently simple
technological solutions can require complex supporting apparatus
pdfcrowd.comopen in browser PRO version Are you a developer? Try out the HTML to PDF API
when implemented in real life.71 However, these findings suggest that
as mRDTs become established, the intensity of supporting
interventions required is likely to reduce. Further research could
explore whether an initial investment in mRDTs could establish
patterns of care that allow for other diagnostic tests to be introduced
more easily in the future.
Conclusion
This analysis shows that uptake and adherence to mRDTs can be high,
but this requires either existing contexts where integrating the tests
into practice already makes sense, or tailored interventions to
encourage this. Basic training and supplies are essential but
insufficient to maximise the potential of mRDTs in contexts where they
do not fit well with the landscape of care. Apparently simple
technological solutions such as mRDTs can require complex
supporting interventions that take account of how they will be
interpreted and used.
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